Extrapulmonary drug-resistant tuberculosis at a drug-resistant tuberculosis center, Mumbai: Our experience – Hope in the midst of despair!

by Unnati Desai, Jyotsna M Joshi
Published 2019-01-01

Treatment of Drug-Resistant Tuberculosis: Current Status

by Rajendra Prasad, Harsh Saxena, Nikhil Gupta, Mohammad Tanzeem, Ronal Naorem
Published 2021-04-01

Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings

by Giovanni Sotgiu, Simon Tiberi, Rosella Centis, Lia D’Ambrosio, Zhenia Fuentes, Alimuddin Zumla, Giovanni Battista Migliori
Published 2017-03-01

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB U...

by Myungsun Lee, Jeongha Mok, Deog Kyeom Kim, Tae Sun Shim, Won-Jung Koh, Doosoo Jeon, Taehoon Lee, Seung Heon Lee, Ju Sang Kim, Jae Seuk Park, Ji Yeon Lee, Song Yee Kim, Jae Ho Lee, Kyung-Wook Jo, Byung Woo Jhun, Young Ae Kang, Joong Hyun Ahn, Chang-Ki Kim, Soyoun Shin, Taeksun Song, Sung Jae Shin, Young Ran Kim, Heejung Ahn, Seokyung Hahn, Ho Jeong Won, Ji Yeon Jang, Sang Nae Cho, Jae-Joon Yim
Published 2019-01-01

Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone

by Pravin K. Singh, Amita Jain
Published 2019-09-01

Effectiveness of the shorter MDR regimen in the management of tuberculosis: Shortfall in the outcome of disease a multidimensional approach and evaluation for a better alternative

by Prasanta Kumar Das, Somtirtha B Ganguly
Published 2020-01-01

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management

by Rajendra Prasad, Nikhil Gupta, Amitabh Banka
Published 2018-01-01

Shorter antibiotic regimens impact the control efforts in high tuberculosis burden regions of Taiwan

by Yi-Jun Lin, Hsing-Chieh Lin, Ying-Fei Yang, Chi-Yun Chen, Tien-Hsuan Lu, Chung-Min Liao
Published 2020-08-01